Stryker Corporation operates as a medical technology company, focusing on two main segments: Orthopaedics and Spine, and MedSurg and Neurotechnology. The Orthopaedics and Spine segment generates revenue through implants for hip and knee joint replacements, spinal implants, and trauma products, contributing approximately 55% of total revenue. The MedSurg and Neurotechnology segment includes surgical equipment, patient handling products, and neurotechnology devices, accounting for around 45% of revenue. Key customers include healthcare providers such as hospitals and clinics across approximately 75 countries. Factors supporting endurance include the growing demand for medical devices and an aging population, while potential limitations include regulatory challenges and competition in the medical technology sector.
—
Stryker Corporation operates as a medical technology company, focusing on two main segments: Orthopaedics and Spine, and MedSurg and Neurotechnology. The Orthopaedics and Spine segment generates revenue through implants for hip and knee joint replacements, spinal implants, and trauma products, contributing approximately 55% of total revenue. The MedSurg and Neurotechnology segment includes surgical equipment, patient handling products, and neurotechnology devices, accounting for around 45% of revenue. Key customers include healthcare providers such as hospitals and clinics across approximately 75 countries. Factors supporting endurance include the growing demand for medical devices and an aging population, while potential limitations include regulatory challenges and competition in the medical technology sector.
—
Daily adjusted close
Stryker Corporation operates as a medical technology company, focusing on two main segments: Orthopaedics and Spine, and MedSurg and Neurotechnology. The Orthopaedics and Spine segment generates revenue through implants for hip and knee joint replacements, spinal implants, and trauma products, contributing approximately 55% of total revenue. The MedSurg and Neurotechnology segment includes surgical equipment, patient handling products, and neurotechnology devices, accounting for around 45% of revenue. Key customers include healthcare providers such as hospitals and clinics across approximately 75 countries. Factors supporting endurance include the growing demand for medical devices and an aging population, while potential limitations include regulatory challenges and competition in the medical technology sector.